Advanced searches left 3/3

Cardiogenic - Crossref

Summarized by Plex Scholar
Last Updated: 10 November 2022

* If you want to update the article please login/register

Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock

Background: Many physicians are unaware that extracorporeal membrane oxygenation can produce the best results under certain circumstances. In this research, we investigated the most effective ECMO treatments in patients with refractory cardiogenic shock. Methods: In our hospital, 23 patients with acute left anterior myocardial infarction, 3 with acute left superior and right ventricular myocardial infarction, and 9 with inflammatory myocardial infarction were treated with ECMO, including 11 patients with acute left anterior myocardial infarction, 3 with acute left anterior myocardial infarction, and 9 with chronic myocardial infarction. Within a day before the removal of ECMO, survivors noticed significant differences in blood pressure, oxygen partial pressure, and left ventricular ejection fractions among survivors and nonsurvivors. ECMO's survival rate is dependent on the reversibility of the primary disease that causes refractory cardiogenic shock.

Source link: https://doi.org/10.1532/hsf.3263


A Dilemma in the Extremely Low-Placed Venus A-Valve in a Cardiogenic Shock Patient

Transcatheter aortic valve replacement is regarded as a viable alternative to balloon aortic valvuloplasty in patients with severe aortic valve stenosis in cardiogenic shock. A poor implant of a transcatheter heart valve can result in a pronounced epithelitic regurgitation and prosthesis-patient mismatch, causing a dilemma in such a situation. Following valve implantation, the hemodynamic conditions of the patient rapidly deteriorated; as a result, cardiopulmonary resuscitation and extracorporeal circulation assistance were initiated. The administration of critical TAVR in cardiogenic shock should be updated and reexamined. To prevent surgical bailout, a common and effective percutaneous approach to deal implant failure of THV is required.

Source link: https://doi.org/10.1532/hsf.3517


A Rare Reason of Cardiogenic Shock and Acute Myocardial Infarction: Aortic Valve Myxoma

Aortic valve myxoma is a rare benign cardiac abnormality. In few studies, the association of aortic valve myxoma with cardiogenic shock and acute myocardial infarction has been documented. Cardiogenic shock and acute myocardial infarction are nonspecific, and we should be aware that patients with cardiogenic shock and acute myocardial infarction may suffer from aortic valve myxoma.

Source link: https://doi.org/10.1532/hsf.4015


Influence of Venoarterial Extracorporeal Membrane Oxygenation Integrated Hemoadsorption on the Early Reversal of Multiorgan and Microcirculatory Dysfunction and Outcome of Refractory Cardiogenic Shock

The aim of this investigation was to determine the effects of venoarterial extracorporeal membrane oxygenation integrated hemoadsorption on multiorgan and microcirculatory dysfunction, as well as early mortality in refractory cardiogenic shock patients. After 72 hours, hospital mortality was similar to the control group's predictions, with lower mean sequential organ failure assessment scores, lactate reduction, PCO2 gap, vasoactive inotropic score, and reduced delta Cu2013reactive protein level in the hemoadsorption compared to control groups.

Source link: https://doi.org/10.3390/jcm11216517


Radiographic features of cardiogenic pulmonary oedema in cats with left-sided cardiac disease: 71 cases

Objectives This study was designed to identify the radiographic signs of cardiogenic pulmonary oedema in a large group of cats with left-sided cardiac disease and the association between CPE's radiographic signs and the underlying cardiac disease. In 97. 2% and 91. 9% of cats, as well as subjective and objective LAE, respectively, were found in 97. 2% and 91. 9% of cats, as well as in 80. 3% and 40. 6%, respectively. In 77. 5% of cats, pulmonary artery abnormalities, including caudal pulmonary artery dilation, were present. In 78% and 55% cats on right lateral and ventrodorsal or dorsoventral views, respectively, right lateral and ventrodorsal and pulmonary vein ratio = 1 was found. Between cats with HCM and RCM, no difference was found for any of these radiographic characteristics.

Source link: https://doi.org/10.1177/1098612x221121922


Refractory Cardiogenic Shock Secondary to Acute Myocarditis in a Child with Multisystem Inflammatory Syndrome Associated with COVID-19: A Case Report

Children with Coronavirus disease 2019 infection typically have mild signs, but they can be diagnosed with a life-threatening disorder called a multisystem inflammatory syndrome. We report a case of COVID-19-related multisystem inflammatory syndrome in an 8-year-old boy who was presenting with cardiogenic shock as a result of acute myocarditis without evidence of Kawasaki disease.

Source link: https://doi.org/10.31729/jnma.6376


Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis

Background: The mortality risk for a patient with a refractory cardiogenic shock on venoarterial extracorporeal membrane oxygenation remains high, and hyperoxia could exacerbate this prognosis. Methods We undertook a retrospective bicenter survey in two French academic centers. Following admission, the absolute peak PaO 2, the mean daily peak PaO 2, the overall mean PaO 2, and the severity of hyperoxia were recorded for 48 hours. The mean daily peak, absolute peak, and overall mean PaO 2 values in non-survivors were much higher than in survivors. The mean daily peak PaO 2, absolute peak PaO 2, and overall mean PaO 2 were all independent predictors of 28-day mortality in a multivariate logistic regression model. Conclusions: Patients on VA-ECMO support for refractory cardiogenic shock had high oxygen levels throughout 28 days, according to their 28-day mortality.

Source link: https://doi.org/10.1186/s13054-022-04133-7


Systemic Inflammatory Burden Correlates with Severity and Predicts Outcomes in Patients with Cardiogenic Shock Supported by a Percutaneous Mechanical Assist Device

Despite the introduction of mechanical circulatory assistance, in-hospital mortality due to cardiogenic shock remains high. In this research, we wanted to see if systemic inflammation is related to clinical outcomes in CS. In 134 patients with CS managed by VA-ECMO or Impella, we retrospectively measured systemic cytokine levels and the neutrophil-to-lymphocyte ratio, a measure of low-grade inflammation. Patients with earlier stages of cardiovascular shock were significantly less in patients with NLR pre-device implantation. In summary, NLR is a widely available indicator of inflammation and correlates with in-hospital mortality among patients of cardiogenic shock who require percutaneous mechanical circulatory assistance.

Source link: https://doi.org/10.1007/s12265-020-10078-5


99mTc-sestamibi and 18F-fluorodeoxyglucose imaging in patients with cardiogenic shock: A pilot study

CS and 16 matched STEMI patients without CS were prospectively recruited. The percentages of impaired perfusion and metabolism in the left ventricle were determined by a total perfusion deficit and total FDG uptake deficit. In 16 patients, MACE was present in 16 patients, and acute TFD was a predictor of MACE in those with CS. Conclusion We concluded in this pilot study that STEMI patients with CS had a significant elevated TPD, which was due to the presence of CS. Acute TFD was associated with rise in LVEF, and it was also predictive of MACE in patients with CS.

Source link: https://doi.org/10.3389/fcvm.2022.1047577


Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support

Abstract Aims cardiogenic dysfunction is a life-threatening condition that can lead to primary cardiac dysfunction. Tachycardia is a common compensatory response to hypotension and low cardiac output, as well as a side effect related to inotropic drugs. In the sinoatrial node, Ivabradine selectively acts on the IKf channel to reduce sinus heart rate without affecting inotropism. Methods and findings We describe the use of ivabradine in six patients with CS underwent veno-arterial membrane oxygenation and a matched cohort of patients with similar characteristics that did not receive ivabradine. b. p. m. The Ivabradine administration's efforts to a dramatic heart rate decline of 20. 83 [95% confidence interval u221227. 2 to u221214. 4] b. p. m. b. p. m. The ventricular native stroke volume of Echo-derived left ventricular native stroke volume had risen by +7. 83 mL with a parallel decrease in VA-ECMO funding [u2212170]. In all patients, Noradrenaline was down-titrated due to the observation period. Conclusions After ivabradine treatment, there was a dramatic decline in heart rate.

Source link: https://doi.org/10.1093/ehjacc/zuac133

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions